Mutai Mamoru | Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
スポンサーリンク
概要
- MUTAI Mamoruの詳細を見る
- 同名の論文著者
- Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporationの論文著者
関連著者
-
Mutai Mamoru
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Mutai M
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Mutai Mamoru
First Department Of Pathology Nagoya City University Medical School
-
MUTAI Mamoru
Toxicology Laboratory, Life Science Research Sector, Mitsubishi Chemical Co. Yokohama Research Cente
-
Mutai Mamoru
Toxicol.lab.life Sci.res.sect.mitsubishi Chemical Co. Ltd.
-
Sugimoto Jiro
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Sugimoto Jirou
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Sugimoto Jiro
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Mutai Mamoru
Toxicology Laboratory Yokohama Research Center Mitsubishi Chemical Corporation.
-
SUGIMOTO Jiro
Toxicology Lab., Mitsubishi Pharm.
-
Asamoto M
Department Of Experimental Pathology And Tumor Biology Nagoya City University Graduate School Of Med
-
Asamoto Makoto
国立がんセンター
-
Asamoto Makoto
住友製薬大阪研究所
-
TSUDA Hiroyuki
Chemotherapy
-
Okada Miyoko
Safety Research Laboratory (Kazusa), Mitsubishi Tanabe Pharma Corporation
-
Tsuda Hiroyuki
1st Dept. Pathol. Nagoya City Univ. Med. Sch.
-
Okada Miyako
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Okada Miyoko
Mitsubishi-tokyo Pharmaceuticals Incorporation Yokohama Research Center Pharmacokinetics And Toxicol
-
Mutai M
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Mutai M
Toxicology Laboratory Pharmaceuticals Research Division Mitsubishi Pharma Corporation
-
Ishii Shun-ichiro
Safety Research Laboratory (Kazusa), Mitsubishi Tanabe Pharma Corporation
-
Asamoto M
Department Of Experimental Pathology And Tumor Biology Graduate School Of Medical Sciences Nagoya Ci
-
ASAMOTO Makoto
Chemotherapy Division, National Cancer Center Research Institute
-
Inoue Yoshimi
Fac. Of Pharmaceutical Sciences Toho Univ.
-
Inoue Yoshimi
Toxicology Laboratory Research And Development Division Mitsubishi Pharma Corporation
-
Asamoto Makoto
Chemotherapy Division National Cancer Center Research Institute
-
OHYAMA Naoki
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
ISHII Shun-ichiro
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
Ohyama Naoki
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Ohyama Naoki
Toxicology Laboratory Mitsubishi Pharma Corporation
-
Takasuka Nobuo
Cancer Prevention Basic Res. Project National Cancer Center Res. Inst.
-
Murakoshi M
Lion Corp. Kanagawa Jpn
-
KUSAKABE Manami
Toxicology Lab., Mitsubishi Pharm.
-
Mori Mie
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
TAKASUKA Nobuo
Chemotherapy
-
Tsuda Hiroyuki
Department Of Molecular Toxicology Nagoya City University Graduate School Of Medical Sciences
-
Tsuda H
Keio Univ. Yokohama‐shi Jpn
-
KRUTOVSKIKH Vladimir
Chemotherapy Division, National Cancer Center Research Institute
-
Mutai Mamoru
Toxicology Laboratory Mitsubishi-tokyo Pharmaceuticals Inc.
-
Kobayashi K
Toxicology Laboratory Research Center Mitsubishi-tokyo Pharmaceuticals. Inc.
-
SANO Fumiko
Toxicology Laboratory, Yokohama Research Center, Mitsubishi Chemical Corporation
-
Sano Fumiko
Toxicology Laboratory Kazusa Research Center Mitsubishi-tokyo Pharmaceuticals Inc.
-
SHIBATA Hiroshi
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
OKADA Miyoko
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
Tsuda H
Dep. Of Molecular Toxicology Nagoya City Univ.
-
Kusakabe Manami
Toxicology Lab. Mitsubishi Pharm.
-
Toriyama‐baba H
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Krutovskikh Vladimir
Chemotherapy Division National Cancer Center Research Institute
-
Maeda M
Ibl
-
KOBAYASHI Kiyoshi
Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals. Inc.
-
GOTO Kazuhiro
Toxicology Laboratory, Life Science Research Sector, Mitsubishi Chemical Co. Yokohama Research Cente
-
ITO Nobuyuki
Nagoya City University
-
SAKAIRI Tetsuya
Toxicology Lab., Mitsubishi Pharm.
-
NISHINO Hoyoku
Department of Biochemistry, Kyoto Prefectural University of Medicine
-
Yamaguchi Shuji
First Department Of Pathology Nagoya City University Medical School
-
Yamaguchi S
Tsurumi Univ. Yokohama Jpn
-
Yamaguchi Shuji
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd
-
BABA-TORIYAMA Hiroyasu
Chemotherapy
-
Nishino Hoyoku
Department Of Biochemistry And Molecular Biology Graduate School Of Medical Science Kyoto Prefectura
-
SEKINE Kazunori
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
TSUCHIYA Takayuki
Toxicology Laboratory, Yokohama Research Center, Mitsubishi Chemical Corporation
-
OOYAMA Naoki
Toxicology Laboratory, Yokohama Research Center, Mitsubishi Chemical Corporation
-
SATO Minoru
Toxicology Laboratory, Yokohama Research Center, Mitsubishi Chemical Corporation
-
SHINTAKU Yoshihisa
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
SUGIYAMA Akio
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
Sakairi Tetsuya
Toxicology Lab. Mitsubishi Pharm.
-
Shimizu Toshinobu
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
Masutomi Naoya
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
Baba-toriyama Hiroyasu
Chemotherapy Division National Cancer Center Research Institute
-
Masutomi Naoya
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Sugiyama Akio
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Tsuchiya Takayuki
Toxicology Laboratory Kazusa Research Center Mitsubishi-tokyo Pharmaceuticals Inc.
-
Ooyama Naoki
Toxicology Laboratory Kazusa Research Center Mitsubishi-tokyo Pharmaceuticals Inc.
-
Tsuchiya T
Tsukuba Safety Assessment Laboratories Banyu Pharmaceutical Co. Ltd.
-
Shimizu Toshinobu
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Inada Ken-ichi
Department Of Pathology Fujita Health University School Of Medicine
-
Tsukamoto T
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
SHIRAI Norimitsu
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
TSUDA Hiroyuki
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
TSUKAMOTO Tetsuya
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
TATEMATSU Masae
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
INADA Ken-ichi
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
SHIMIZU Nobuyuki
Laboratory of Pathology, Aichi Cancer Research Institute
-
NAKANISHI Hayao
Laboratory of Pathology, Aichi Cancer Research Institute
-
KOBAYASHI Kiyoshi
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
KAKIZOE Tadao
National Cancer Center Hospital
-
Takegawa Kiyoshi
Toxicology Lab. Mitsubishi Pharm.
-
Imaida Katsumi
大雄会医科学研究所
-
Imaida Katsumi
1st Dept. Pathol. Nagoya City Univ. Med. Sch.
-
TAKAGI Shiro
Toxicology Lab., Mitsubishi Pharm.
-
Kakizoe T
President National Cancer Center
-
Kakizoe T
National Cancer Center Hospital Tokyo
-
NAKANISHI Hayao
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
NAKAMURA Atsushi
1st Dept. Pathol., Nagoya City Univ. Med. Sch.
-
YAMAGUCHI Shuji
1st Dept. Pathol., Nagoya City Univ. Med. Sch.
-
MUTAI Mamoru
1st Dept. Pathol., Nagoya City Univ. Med. Sch.
-
TSUDA Hiroyuki
1st Dept. Pathol., Nagoya City Univ. Med. Sch.
-
ITO Nobuyuki
1st Dept. Pathol., Nagoya City Univ. Med. Sch.
-
LEE Yong-Soon
College of Veterinary Medicine, Seoul National University
-
Inada Ken-ichi
愛知県がんセンター研究所 腫瘍病理学部
-
Inada Ken-ichi
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
稲田 健一
Department Of Pathology Fujita Health University School Of Medicine
-
Kakizoe Tadao
President National Cancer Center
-
Ube Masayuki
Safety Research Laboratory (Kazusa), Mitsubishi Tanabe Pharma Corporation
-
Inada K
Department Of Pathology Fujita Health University School Of Medicine
-
Inoue Yoshimi
Toxicology Laboratory Yokohama Research Center Mitsubishi Chemical Corporation.
-
AOKI Toyohiko
Drug Safety Research Laboratories, Eisai Co., Ltd.
-
Tatematsu M
愛知県がんセンター研究所 腫瘍病理学部
-
Kato Toshio
First Dept. of Med. Osaka Univ. Med. School
-
A. Moore
Chemotherapy Division National Cancer Center Research Institute
-
Ube Masayuki
第一三共安全性研究所
-
Ube Masayuki
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Takagi Shiro
Safety Evaluation Laboratory Yoshitomi Pharmaceutical Industries Co. Ltd.
-
Takagi Shiro
Research Laboratories Yoshitomi Pharmaceutical Industries
-
Takagi Shiro
Toxicology Lab. Mitsubishi Pharm.
-
Takagi Shiro
Drug Discovery Laboratories Pharmaceutical Research Division Welfide Co.
-
Iigo M
National Cancer Res. Inst. Tokyo
-
Iigo Masaaki
Cancer Prevention Basic Res. Project National Cancer Center Res. Inst.
-
Iigo Masaaki
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Aoki Toyohiko
Drug Safety Research Laboratories Eisai Co. Ltd.
-
Ozaki Keisuke
First Department Of Pathology Nagoya City University Medical School
-
Kakizoe T
National Cancer Center Tokyo
-
Kakizoe Tadao
National Cancer Center
-
Iwahori Yoshio
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
IWAHORI Yoshio
Chemotherapy
-
HORI Takaaki
Chemotherapy
-
JOONG KIM
Chemotherapy
-
Tsuda Hiroyuki
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Nishino H
Department Of Biochemistry Kyoto Prefectural University Of Medicine
-
Nishino H
Department Of Biochemistry And Molecular Biology Kyoto Prefectural University Of Medicine
-
ADACHI Tamiko
Safety Research Laboratory
-
MAEDA Mitsuaki
Chemotherapy Division, National Cancer Center Research Institute
-
Uno Yoshifumi
Safety Research Laboratory Mitsubishi Tanabe Parma Co.
-
TAKASUKA Nobuo
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
OTA Tomonori
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
USHIDA Yoshihiko
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
KUHARA Tetsuya
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
MAEDA Mitsuaki
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
TORIYAMA-BABA Hiroyasu
Chemotherapy Division, National Cancer Center Research Institute
-
MURAKOSHI Michiaki
Lion Corporation
-
SEKINE Kazunori
Chemotherapy Division, National Cancer Center Research Institute
-
WATANABE Emiko
Chemotherapy Division, National Cancer Center Research Institute
-
NAKAMURA Joe
Chemotherapy Division, National Cancer Center Research Institute
-
KIM Dae
Chemotherapy Division, National Cancer Center Research Institute
-
OTA Tomonori
Chemotherapy Division, National Cancer Center Research Institute
-
MASUDA Mitsuharu
Cancer Prevention Division, National Cancer Center Research Institute
-
SUGIMOTO Hajime
Cancer Prevention Division, National Cancer Center Research Institute
-
WADA Shigetsugu
First Department of Pathology, Nagoya City University Medical School
-
Shimizu N
Univ. Tokyo Tokyo Jpn
-
Nakanishi H
愛知県がんセンター研究所 腫瘍病理学部
-
Nakanishi Hayao
Laboratory Of Pathology Aichi Cancer Center Research Institute
-
Sekine Kazunori
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Ishiguro Masaji
Loboratory Of Chemistry For Natural Products Tokyo Institute Of Technology
-
Kato Toshio
First Department Of Pathology Nagoya City University Medical School
-
Inoue Yoshimi
Safety Research Laboratory (Kazusa), Mitsubishi Tanabe Pharma Corporation
-
Mutai Mamoru
Safety Research Laboratory (Kazusa), Mitsubishi Tanabe Pharma Corporation
-
OKADA Miyako
Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Ph
-
WASAKI Masahiko
Toxicology laboratory, Mitsubishi-Tokyo Pharmaceuticals, Inc.
-
SUBIMOTO Jiro
Toxicology laboratory, Mitsubishi-Tokyo Pharmaceuticals, Inc.
-
INOUE Hiroaki
Toxicology laboratory, Mitsubishi-Tokyo Pharmaceuticals, Inc.
-
Sakairi Tetsuya
Toxicology Laboratory Research And Development Division Mitsubishi Pharma Corporation
-
Wada Shigetsugu
First Department Of Pathology Nagoya City University Medical School
-
Mori Mie
Kashima Laboratory, Mitsubishi Chemical Safety Institute, Ltd.
-
Oohori Yuji
Kashima Laboratory, Mitsubishi Chemical Safety Institute, Ltd.
-
Tatematsu Masae
Laboratory Of Pathology Aichi Cancer Center Research Institute
-
Shirai Norimitsu
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Kawaguchi Takanori
2nd Department Of Pathology Fukushima Medical University School Of Medicine
-
Yamaguchi Shuji
1st Dept. Pathol. Nagoya City Univ. Med. Sch.
-
Uno Yoshifumi
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Tsuda Hiroyuki
1st Department Of Pathology Nagoya City University Medical School
-
Inoue Yoshimi
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Nakayama Kouji
Kashima Laboratory Mitsubishi Chemical Safety Institute Ltd.
-
Ito Nobuyuki
1st Dep Of Surg. Cardiovasc. Diag. Lab.
-
Oohori Yuji
Kashima Laboratory Mitsubishi Chemical Safety Institute Ltd.
-
Nakamura Joe
Chemotherapy Division National Cancer Center Research Institute
-
Hori Takaaki
First Department Of Pathology Osaka City University Medical School
-
Inoue Hiroaki
Toxicology Laboratory Pharmaceuticals Resaerch Division Mitsubishi Pharma Corporation
-
Adachi Tamiko
Safety Research Laboratory (kashima) Mitsubishi Tanabe Pharma Corporation
-
Imaida Katsumi
1st Dept. Of Pathology Nagoya City University Medicdl School
-
Watanabe Emiko
Chemotherapy Division National Cancer Center Research Institute
-
Kuhara Tetsuya
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
SEKIJIMA Masaru
Kashima Laboratory, Mitsubishi Chemical Safety Institute LTD.
-
Kim Dae
Chemotherapy Division National Cancer Center Research Institute
-
MURAKAMI Tomoko
Toxicology Laboratory, Kazusa Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc.
-
Nakanishi H
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Takasuka N
National Cancer Center Res. Inst. Tokyo Jpn
-
Ota Tomonori
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Subimoto Jiro
Toxicology Laboratory Mitsubishi-tokyo Pharmaceuticals Inc.
-
SUGIMOTO Jiro
Mitsubishi-Tokyo Pharmaceuticals, Incorporation, Yokohama Research Center, Pharmacokinetics and Toxi
-
UMEDA Asami
Mitsubishi-Tokyo Pharmaceuticals, Incorporation, Yokohama Research Center, Pharmaceuticals Research
-
KUSAKABE Manami
Mitsubishi-Tokyo Pharmaceuticals, Incorporation, Yokohama Research Center, Pharmacokinetics and Toxi
-
WAZAKI Masahiko
Mitsubishi-Tokyo Pharmaceuticals, Incorporation, Yokohama Research Center, Pharmacokinetics and Toxi
-
MUTAI Mamoru
Mitsubishi-Tokyo Pharmaceuticals, Incorporation, Yokohama Research Center, Pharmacokinetics and Toxi
-
Adachi Tamiko
Safety Res. Lab. (kashima) Mitsubishi Tanabe Pharma Corp.
-
Takasuka Nobuo
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Ushida Yoshihiko
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Aoki Toyohiko
Drug Safety Japan Global Drug Safety Biopharmaceutical Assessments Core Function Unit
-
Lee Yong-soon
College Of Veterinary Medicine Seoul National University
-
Lee Yong-soon
College Of Vet.med. Seoul National University
-
Tsukamoto Tetsuya
Laboratory Of Pathology Aichi Cancer Center Research Institute
著作論文
- Dose-dependent Promoting Effects of Catechol on Glandular Stomach Carcinogenesis in BALB/c Mice Initiated with N-Methyl-N-nitrosourea
- P8-29 The left lobe model as an improved mouse pulmonary fibrosis model by intratracheal bleomycin administration(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- B31 DETECTION OF HEPATOCARCINOGENIC POTENTIAL OF 5 CHEMICALS BY A MEDIUM-TERM BIOASSAY SYSTEM
- Possible Chemopreventive Effects of Bovine Lactoferrin on Esophagus and Lung Carcinogenesis in the Rat
- Differential Dose-dependent Effects of α-, β-Carotenes and Lycopene on Gap-junctional Intercellular Communication in Rat Liver in vivo
- Inhibition of Azoxymethane-initiated Colon Tumor by Bovine Lactoferrin Administration in F344 Rats
- Triazine Derivatives Inhibit Rat Hepatocarcinogenesis but Do Not Enhance Gap Junctional Intercellular Communication
- Modifying Influence of Swine Serum-induced Liver Fibrosis on Development of Preneoplastic Lesions in Rat Liver
- 22A-10-3 Detection of Dibromoacetic acid-induced histopathological changes in testes and epididymides of rats by 2-weeks repeated dose toxicity study.
- 21C-10-2 Detection of carcinogenic potential of Diethylstibestrol (DES) and N-methyl-N-nitrosourea (MNU) by the alternative testing model using Tg-rasH2 mouse
- Collaborative work on evaluation of ovarian toxicity : 17) Two- or four-week repeated-dose studies and fertility study of sulpiride in female rats
- Effect of dosing interval between edaravone and cefalotin/glycerol on the nephrotoxicity in rats(Kidney, Urinary system, Proceedings of the 32nd Annual Meeting)
- P7-14 Renal Toxicity of Furosemide in Rats : Effects of Water-Deprived Condition or Coadministration of Cefalotin and Glycerol(IMMUNE AND ALLERGIC SYSTEM/KIDNEYS AND URINARY EXCRETION SYSTEM/CYTOTOXICITY/OTHERS-1)(GENERAL SESSION BY POSTER PRESENTATION)(P
- O-22 Nephrotoxic effect of edaravone in combination with cefalotin and glycerol in rats(KIDNEYS AND URINARY EXCRETION SYSTEM)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P11-09 Glucose Alters the Susceptibility of Mesangial Cells to Contrast Media.
- Metabonomic analysis of rat urine following single dose of α-naphthylisothiocyanate (ANIT) or puromycin aminonucleoside (PAN) (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Gene expression profiling of rat kidneys following dose of edaravone in combination with cefalotin and glycerol(Kidney, Urinary system, Proceedings of the 32nd Annual Meeting)
- COLLABORATIVE WORK TO EVALUATE TOXICITY ON MALE REPRODUCTIVE ORGANS BY REPEATED DOSE STUDIES IN RATS : 25)EFFECTS OF 2- AND 4- WEEK REPEATED-DOSING OF DIBROMOACETIC ACID
- Effects of Salt Loading on Glomeruli in the Remnant Kidney Model
- Report 4 : CASE STUDY OF CARCINOGENICITY BY INITIATION-PROMOTION MODEL (CARCINOGENlClTY STUDIES)